Alerts

We're continuing to monitor adverse events from masks that have magnets interacting with implantable medical devices. Find out how we're working with companies supplying these devices in Australia and international regulators.

Interpharma Pty Ltd is recalling all batches of Sodium Chloride 0.9% 30mL ampoules due to potential contamination with Ralstonia pickettii. You can return them for a refund.

We're continuing to investigate and take action about the potential contamination of some saline products with Ralstonia pickettii. Read about a product recall and quarantines.

The availability of all strengths of Mounjaro (tirzepatide) will be limited until 31 August 2024, due to unexpected high demand. Patients and healthcare professionals should check the Medicine Shortage Reports Database for the latest supply information.

We're aware of Ralstonia pickettii cases in patients across Australia and are working closely with health departments to investigate the possible role of therapeutic goods.

Read information for consumers and health professionals about low levels of nitrosamine impurity in medicines containing duloxetine.

Find out how we are investigating low levels of the nitrosamine impurity in medicines containing fluoxetine. Read information for consumers and health professionals.

There's a shortage of fluoxetine 20 mg dispersible tablets (Zactin Tabs) due to manufacturing issues. The shortage is expected to continue until 29 February 2024.

If you've purchased APOHEALTH Paracetamol Pain Relief paracetamol 500 mg film-coated tablets in a bottle, ensure it is kept out of reach of children. This product does not have child-resistant packaging.

ResMed Pty Ltd is updating the safety information and warnings for their masks that have magnets.

FIT-BioCeuticals Pty Ltd is recalling two batches of BioCeuticals Zinc Drops. In these batches, the zinc and the liquid are separating, which means that you may not get the correct dose of zinc.

If you use a glucose monitoring device or system, it may be affected by the Optus mobile and WiFi outage. Be alert and report any concerns to your health care professional.

The substitution instrument for oral cefalexin liquid products has been extended to 30 April 2024. This will assist with timely access for patients using oral cefalexin syrups and suspensions.

If you've purchased this sunscreen, do not spray it directly on your face. Spray the sunscreen onto your hands and then apply on your face.

If you take baclofen, or care for someone who does, it's important to be alert to the risks of overdose. The risks are greater when using high doses for treating alcohol-use disorder.

Metagenics (Aust) Pty Ltd is recalling a batch of Ethical Nutrients Mega Magnesium Raspberry Powder, due to high pyridoxine (Vitamin B6) content. Read more about the recall.

GlucaGen HypoKit (glucagon) shortage will be extended by one month to 31 October 2023

Find out about a software problem with the SmartDrive MX2+ App, for the PushTracker E2 and E3 wearable watches, causing safety issues for operating manual wheelchairs.

Read advice about not prescribing Ozempic to new patients unless there are no suitable alternatives or there is a compelling clinical reason.

To help manage the shortage of the tablet form of vigabatrin (Sabril), we have made a Serious Scarcity Substitution Instrument that allows a pharmacist to provide the oral sachets.

Felton Grimwade & Bosisto’s Pty Ltd is recalling some batches of the Euky Bear Warm Steam Vaporiser - Humidifier because the enclosed heating element can overheat.

Be alert to an issue affecting all units of the Scandinavian Total Ankle Replacement (STAR) Ankle Prosthesis supplied in the Australian market.

Read about the supply of Ordine (morphine) oral liquid being discontinued in Australia between November 2023 and early 2024.

The shortage of Metalyse (tenecteplase) is now resolved.

The TGA has received reports of liver problems experienced by consumers taking medicines containing turmeric or curcumin.